	Years of Life Lost From Metastatic Prostate Cancer According to Treatment Era and Race/Ethnicity. Prostate Quarta L, Petix M, Filzmayer M, Orlandi F, Polverino F, Goyal JA, Ferro M, Chun FKH, Micali S, Longo N, Shariat SF, Barletta F, Stabile A, Gandaglia G, Montorsi F, Saad F, Briganti A, Karakiewicz PI. PMID: 42335306 [PubMed - as supplied by publisher]
	Contrast-Enhanced Ultrasound as a Next-Step Tool After Indeterminate CT in ESRD. Ultrasound Q Mc Caughey M, Gustainis D, Ambrosio M, Sambommatsu Y, Imai D, Sharma A, Khan A, Lee SD, Bruno D, Prasad U, Saeed M. PMID: 42335288 [PubMed - indexed for MEDLINE]
	Correlation of Prostate Tumor Laterality with Pelvic Lymph Node Metastasis Patterns- A Retrospective Observational Study. Urol Int Masoumi N, Alinejad Khorram A, Beheshti M, Rabani S, Torabi A, Razi A, Jafarlou D. PMID: 42334984 [PubMed - as supplied by publisher]
	Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study. Minerva Urol Nephrol Rescigno P, Taha T, Fita MJ, Matthews D, Fujita K, Lolli C, DI Costanzo F, Juárez A, Ürün Y, Yazgan SC, Li H, Facchini G, Quiroga MN, Sammarco E, Bögemann M, Santini D, Baranseh J, Roviello G, Kopp RM, Fiala O, Büttner T, Carrozza F, Ansari J, Tural D, Conteduca V, Molina-Cerrillo J, Alonso-Gordoa T, Bourlon MT, Palacios GA, Paolieri F, Zgura A, DI Rocco R, Lacerenza LG, Matrana MR, Martignetti A, Massari F, Soares A, Monteiro FS, Bastos DA, Gaughan L, Wenzel M, Mandel P, Banna GL, Santoni M. PMID: 42334408 [PubMed - as supplied by publisher]
	Clinically Significant Prostate Cancer in Patients Undergoing Holmium Laser Enucleation of Prostate for Benign Hyperplasia: A Preoperative Nomogram and a Postoperative Surveillance Protocol. J Endourol Singh G, Bakbak H, Abdelaziz A, Resnik S, Ospina JV, Katz JE, Marcovich R, Khandekar A, Punnen S, Gonzalgo ML, Parekh DJ, Shah HN. PMID: 42333981 [PubMed - as supplied by publisher]
	UBE2C contributes to malignant phenotypes in clear cell renal cell carcinoma via cell cycle and apoptosis regulation. PeerJ Qin T, Liang J, Ya W, Long Y, Wu J, Meng D, Gan F. PMID: 42333228 [PubMed - indexed for MEDLINE]
	Hugoâ„¢ RAS versus da Vinci(Â®) for robot-assisted radical prostatectomy in localized prostate cancer: a GRADE-assessed systematic review and meta-analysis of prospective comparative studies. BMC Surg Mirza W, Haider MH, Habib T, Ali RN, Moeen-Ud-Din MB, Hadhoud AM. PMID: 42332746 [PubMed - as supplied by publisher]
	Exploring the relationship between potential hepatotoxicity and novel hormonal therapies in prostate cancer: a systematic review and meta-analysis. BMC Cancer Ma L, Fan L, Luo X, Huang Z, Dai J, Wu Y, Zhang W. PMID: 42332688 [PubMed - as supplied by publisher]
	A stratified urine-based molecular diagnostic and prognostic model for non-muscle-invasive bladder cancer management. BMC Cancer Yi L, Ma Z, Zhang J, Zhan Y, Xiao H, Dai K, Liu Y, Gao Y, Yang X, Cao D, Xu D, Huang H. PMID: 42332658 [PubMed - as supplied by publisher]
	Prostate cancer and diabetes: A retrospective analysis of mortality trends in the United States (1999-2024). Medicine (Baltimore) Shahab SH, Mustafa FE, Masood HG, Ahmed S, Ali F, Sajid Y, Nazir A, Khalid M. PMID: 42332456 [PubMed - indexed for MEDLINE]
	Consistency of multiparametric MRI-guided transperineal prostate biopsy and Gleason score after radical prostatectomy: A retrospective observational study. Medicine (Baltimore) Wu Y, Xu L. PMID: 42332444 [PubMed - indexed for MEDLINE]
	The burden of cardiovascular disease in prostate cancer: prevalence, pathophysiology, and implications for integrated care. Support Care Cancer Ogieuhi IJ, Anthony CS, Ajekiigbe VO, Ayomikun AF, Iyawe EP, Adegbesan CA, Adeshina GA, Moradeyo A, Akingbola A, Ogunniyi KE. PMID: 42332138 [PubMed - indexed for MEDLINE]
	Comment on: cardiovascular and prostate cancer risk associated to testosterone replacement therapy-a systematic review and meta-analysis of 41 randomized controlled trials. Int J Impot Res Sansone A, Jannini EA. PMID: 42332077 [PubMed - as supplied by publisher]
	PROTEUS trial heralds perioperative therapy for prostate cancer. Nat Med O'Leary K. PMID: 42331980 [PubMed - as supplied by publisher]
	Optimising the prostate cancer diagnostic pathway in a tertiary hospital in Karachi: a two-cycle quality improvement project. BMJ Open Qual Samad S, Samad H. PMID: 42331392 [PubMed - indexed for MEDLINE]
	Predicting Renal Tumor Pathology from Intraoperative Gross Appearance: An AI-Based Pilot Study. Urology Patel MH, Lodha R, Millan B, Blachman-Braun R, Loebach L, Pramod N, Saini J, Koller C, Stecko H, Gurram S, Turkbey B, Linehan WM, Ball MW. PMID: 42331293 [PubMed - as supplied by publisher]
	Trophoblast cell-surface antigen 2 evaluation in intraepithelial neoplasia and intraductal carcinoma of the prostate: An immunopathological study. Tissue Cell Fantone S, Tossetta G, Sanguedolce F, Goteri G, Marzioni D, Mazzucchelli R. PMID: 42330802 [PubMed - as supplied by publisher]
	Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up. Ann Intern Med Palsdottir T, Micoli C, Eklund M, Grönberg H, Jäderling F, Tilki D, Lin DW, Cooperberg MR, Eggener SE, Oeffinger KC, Nordström T, Vigneswaran HT. PMID: 42330502 [PubMed - as supplied by publisher]
	Summary for Patients: Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study. Ann Intern Med PMID: 42330499 [PubMed - as supplied by publisher]
	Tumor-associated M2 macrophages promote prostate cancer invasion through the M-CSF-PCLAF pathway. PLoS One Ou Y, Ye C, Jiang H, Zhu Y, Xia C, Yang D. PMID: 42329914 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 179181

Page 1 of 8960



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy